Valeant Pharmaceuticals (VRX) volatility spikes into Q3 and outlook

November 1, 2016 12:30 PM EDT

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Valeant Pharmaceuticals (VRX) 11/4 call option implied volatility is at 92, 11/11 s at 161; compared to its 52-week range of 53 to 173 into the expected release of Q3 results next week.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Options, Trader Talk

Related Entities

Options

Add Your Comment